-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, CNkPBBnZBJYOhRaI0svV7ABdwhnEgCzbL+xWNx0LN9rtUqEEaIhPYiEWMHPUeYSl t2CtmYH5rHAaWkW7PsMp0Q== 0000950134-08-015436.txt : 20080819 0000950134-08-015436.hdr.sgml : 20080819 20080818175022 ACCESSION NUMBER: 0000950134-08-015436 CONFORMED SUBMISSION TYPE: 25 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20080819 DATE AS OF CHANGE: 20080818 EFFECTIVENESS DATE: 20080819 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CHAD THERAPEUTICS INC CENTRAL INDEX KEY: 0000713492 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 953792700 STATE OF INCORPORATION: CA FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 25 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12214 FILM NUMBER: 081025927 BUSINESS ADDRESS: STREET 1: 21622 PLUMMER STREET CITY: CHATSWORTH STATE: CA ZIP: 91311 BUSINESS PHONE: 8188820883 MAIL ADDRESS: STREET 1: 21622 PLUMMER STREET CITY: CHATSWORTH STATE: CA ZIP: 91311 25 1 v43097e25.htm FORM 25 e25
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 25
NOTIFICATION OF REMOVAL FROM LISTING AND/OR
REGISTRATION UNDER SECTION 12(b) OF THE
SECURITIES EXCHANGE ACT OF 1934.
Commission File Number 1-12214
CHAD Therapeutics, Inc.; American Stock Exchange LLC
 
(Exact name of Issuer as specified in its charter; and name of Exchange where security is listed and/or registered)


10200 Mason Avenue, Suite 114, Chatsworth, California 91311, (818) 882-0883
 
(Address, including zip code, and telephone number, including area code, of Issuer’s principal executive offices)


Common Shares, $.01 par value
 
(Description of class of securities)
Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:
     
o
  17 CFR 240.12d2-2(a)(1)
 
    
o
  17 CFR 240.12d2-(a)(2)
 
    
o
  17 CFR 240.12d2-2(a)(3)
 
    
o
  17 CFR 240.12d2-2(a)(4)
 
    
o
  Pursuant to 17 CFR240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange.1
 
    
x
  Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with the rules of the Exchange and the requirements of 17 CFR 240.12d2-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.
 
1   Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.
 
 

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, CHAD Therapeutics, Inc. certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.
         
  CHAD Therapeutics, Inc.
 		  
Date: August 19, 2008  By:   /s/ Earl L. Yager    
    Name:   Earl L. Yager   
    Title:   Chief Executive Officer   
 

 

-----END PRIVACY-ENHANCED MESSAGE-----